A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. PubChem
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Alphacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Alphacetylmethadol. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Alphacetylmethadol. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Alphacetylmethadol. |
| Hydrocodone | Alphacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Alphacetylmethadol. |
| Magnesium sulfate | The therapeutic efficacy of Alphacetylmethadol can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Alphacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Alphacetylmethadol may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Alphacetylmethadol. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Alphacetylmethadol. |
| Orphenadrine | Alphacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Alphacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Alphacetylmethadol. |
| Pramipexole | Alphacetylmethadol may increase the sedative activities of Pramipexole. |
| Ropinirole | Alphacetylmethadol may increase the sedative activities of Ropinirole. |
| Rotigotine | Alphacetylmethadol may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Alphacetylmethadol. |
| Sodium oxybate | Alphacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Alphacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Alphacetylmethadol. |
| Thalidomide | Alphacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Alphacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Alvimopan | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Alvimopan. |
| Desmopressin | The risk or severity of hyponatremia can be increased when Alphacetylmethadol is combined with Desmopressin. |
| Morphine | The risk or severity of adverse effects can be increased when Morphine is combined with Alphacetylmethadol. |
| Codeine | The risk or severity of adverse effects can be increased when Codeine is combined with Alphacetylmethadol. |
| Hydromorphone | The risk or severity of adverse effects can be increased when Hydromorphone is combined with Alphacetylmethadol. |
| Meperidine | The risk or severity of adverse effects can be increased when Meperidine is combined with Alphacetylmethadol. |
| Oxycodone | The risk or severity of adverse effects can be increased when Oxycodone is combined with Alphacetylmethadol. |
| Dextropropoxyphene | The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Alphacetylmethadol. |
| Naltrexone | The therapeutic efficacy of Alphacetylmethadol can be decreased when used in combination with Naltrexone. |
| Sufentanil | The risk or severity of adverse effects can be increased when Sufentanil is combined with Alphacetylmethadol. |
| Alfentanil | The risk or severity of adverse effects can be increased when Alfentanil is combined with Alphacetylmethadol. |
| Fentanyl | The risk or severity of adverse effects can be increased when Fentanyl is combined with Alphacetylmethadol. |
| Levorphanol | The risk or severity of adverse effects can be increased when Levorphanol is combined with Alphacetylmethadol. |
| Remifentanil | The risk or severity of adverse effects can be increased when Remifentanil is combined with Alphacetylmethadol. |
| Diphenoxylate | The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Alphacetylmethadol. |
| Oxymorphone | The risk or severity of adverse effects can be increased when Oxymorphone is combined with Alphacetylmethadol. |
| Dezocine | The risk or severity of adverse effects can be increased when Dezocine is combined with Alphacetylmethadol. |
| Methadyl acetate | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Alphacetylmethadol. |
| Dihydroetorphine | The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Alphacetylmethadol. |
| Diamorphine | The risk or severity of adverse effects can be increased when Diamorphine is combined with Alphacetylmethadol. |
| Bezitramide | The risk or severity of adverse effects can be increased when Bezitramide is combined with Alphacetylmethadol. |
| Ethylmorphine | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Alphacetylmethadol. |
| Etorphine | The risk or severity of adverse effects can be increased when Etorphine is combined with Alphacetylmethadol. |
| Dextromoramide | The risk or severity of adverse effects can be increased when Dextromoramide is combined with Alphacetylmethadol. |
| Desomorphine | The risk or severity of adverse effects can be increased when Desomorphine is combined with Alphacetylmethadol. |
| Carfentanil | The risk or severity of adverse effects can be increased when Carfentanil is combined with Alphacetylmethadol. |
| Dihydrocodeine | The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Alphacetylmethadol. |
| Dihydromorphine | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Dihydromorphine. |
| Ketobemidone | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Ketobemidone. |
| DPDPE | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with DPDPE. |
| Lofentanil | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Lofentanil. |
| Opium | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Opium. |
| Normethadone | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Normethadone. |
| Piritramide | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Piritramide. |
| Alphaprodine | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Alphaprodine. |
| Nicomorphine | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Nicomorphine. |
| Meptazinol | The therapeutic efficacy of Alphacetylmethadol can be decreased when used in combination with Meptazinol. |
| Phenoperidine | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Phenoperidine. |
| Phenazocine | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Phenazocine. |
| Tilidine | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Tilidine. |
| Carfentanil, C-11 | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Carfentanil, C-11. |
| Naloxegol | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Naloxegol. |
| Benzhydrocodone | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Benzhydrocodone. |
| Pegvisomant | The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Alphacetylmethadol. |
| Succinylcholine | The risk or severity of bradycardia can be increased when Succinylcholine is combined with Alphacetylmethadol. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Alphacetylmethadol. |
| Linezolid | The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Alphacetylmethadol. |
| Mirtazapine | Alphacetylmethadol may increase the serotonergic activities of Mirtazapine. |
| Fluvoxamine | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Fluvoxamine. |
| Citalopram | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Citalopram. |
| Duloxetine | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Duloxetine. |
| Paroxetine | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Paroxetine. |
| Sertraline | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Sertraline. |
| Sibutramine | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Sibutramine. |
| Nefazodone | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Nefazodone. |
| Zimelidine | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Zimelidine. |
| Dapoxetine | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Dapoxetine. |
| Milnacipran | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Alphacetylmethadol. |
| Seproxetine | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Seproxetine. |
| Levomilnacipran | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Levomilnacipran. |
| Indalpine | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Indalpine. |
| Ritanserin | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Ritanserin. |
| Alaproclate | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Alaproclate. |
| Ethanol | Alphacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Alphacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Alphacetylmethadol. |
| Phentermine | Phentermine may increase the analgesic activities of Alphacetylmethadol. |
| Pseudoephedrine | Pseudoephedrine may increase the analgesic activities of Alphacetylmethadol. |
| Benzphetamine | Benzphetamine may increase the analgesic activities of Alphacetylmethadol. |
| Diethylpropion | Diethylpropion may increase the analgesic activities of Alphacetylmethadol. |
| Lisdexamfetamine | The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Lisdexamfetamine. |
| Mephentermine | Mephentermine may increase the analgesic activities of Alphacetylmethadol. |
| MMDA | MMDA may increase the analgesic activities of Alphacetylmethadol. |
| Midomafetamine | Midomafetamine may increase the analgesic activities of Alphacetylmethadol. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may increase the analgesic activities of Alphacetylmethadol. |
| 4-Bromo-2,5-dimethoxyamphetamine | 4-Bromo-2,5-dimethoxyamphetamine may increase the analgesic activities of Alphacetylmethadol. |